DataCloudKnowledgetrainingcoordination

L1000 LINCS DCIC FIBR038 MCLF035SZ 6H B23 oligomycin-a 2.22uM.tsv.gz (File)

Taxon:

Homo sapiens

Taxon (Entity type)

Subject:

MCLF035SZ

Subject (Entity type)

Project:

LINCS-2021

Project (Entity type)

File Format:

TSV

File Format (Entity type)

Dcc Asset:

datapackage.zip

Processed File (Entity type)

Dcc:

LINCS

DCC (Entity type)

Data Type:

gene expression profile

Data Type (Entity type)

Compression Format:

GZIP format

File Format (Entity type)

Biosample:

L1000 LINCS DCIC 2021 FIBR038 MCLF035SZ 6H B23 oligomycin-a 2.22uM

Biosample (Entity type)

Assay Type:

landmark transcript profiling assay

Assay Type (Entity type)

Uncompressed Size In Bytes:311 KB

Size In Bytes:127 KB

Sha256:411917411479732eff501ae584d6984d25f3f43cc0890e4681ef05146adedb3f

Persistent Id:drs://drs.lincs-dcic.org/90df5c0b43b75af340186cf969d59f4e

Mime Type:application/gzip

Md5:90df5c0b43b75af340186cf969d59f4e

Filename:L1000_LINCS_DCIC_FIBR038_MCLF035SZ_6H_B23_oligomycin-a_2.22uM.tsv.gz

Creation Time:2021-01-21T00:00:00

Access Url:

drs://drs.lincs-dcic.org/90df5c0b43b75af340186cf969d59f4e

Results found

Linked to

	Label	Description
	L1000 LINCS DCIC 2021 FIBR038 MCLF035SZ 6H B23 oligomycin-a 2.22uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project

L1000 LINCS DCIC 2021 FIBR038 MCLF035SZ 6H B23 oligomycin-a 2.22uM

Biosample (Entity type)

A biosample from LINCS produced as part of the LINCS 2021 project

DISPLAY PER PAGE

Consortium

Community

Resources

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.